- call +1-201-465-4211
- email sales@mrinsights.biz
Cognitive enhancers are drugs and supplements, which are majorly used to treat patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging.
Scope of the Report:
This report focuses on the Cognitive and Memory Enhancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The major factors that drive the growth of the global cognitive and memory enhancer drugs market include surge in geriatric population and rise in prevalence of neurological & memory-related disorders. Furthermore, the benefits offered by cognitive drugs such as improved memory and reasoning propel the market growth. However, ethical issues related to the use of these drugs restrict the market growth.
The worldwide market for Cognitive and Memory Enhancer Drugs is expected to grow at a CAGR of roughly 8.7% over the next five years, will reach 6810 million US$ in 2023, from 4130 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer Inc.
Eisai Co., Ltd.
Allergan, Inc.
Novartis AG
Shire
Johnson & Johnson
Takeda Pharmaceutical Company Limited
AlternaScript LLC
Cephalon, Inc.
Ceretropic.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Aricept
Exelon
Namenda
Razadyne
Provigil
Ritalin
Adderall
Others
Market Segment by Applications, can be divided into
Disease Treatment
Academic Performance
Athletic Performance
Others
There are 15 Chapters to deeply display the global Cognitive and Memory Enhancer Drugs market.
Chapter 1, to describe Cognitive and Memory Enhancer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cognitive and Memory Enhancer Drugs, with sales, revenue, and price of Cognitive and Memory Enhancer Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cognitive and Memory Enhancer Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cognitive and Memory Enhancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cognitive and Memory Enhancer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cognitive and Memory Enhancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Aricept
1.2.2 Exelon
1.2.3 Namenda
1.2.4 Razadyne
1.2.5 Provigil
1.2.6 Ritalin
1.2.7 Adderall
1.2.8 Others
1.3 Market Analysis by Applications
1.3.1 Disease Treatment
1.3.2 Academic Performance
1.3.3 Athletic Performance
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Business Overview
2.1.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Inc. Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai Co., Ltd.
2.2.1 Business Overview
2.2.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Co., Ltd. Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Allergan, Inc.
2.3.1 Business Overview
2.3.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Allergan, Inc. Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis AG
2.4.1 Business Overview
2.4.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis AG Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Shire
2.5.1 Business Overview
2.5.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Shire Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Takeda Pharmaceutical Company Limited
2.7.1 Business Overview
2.7.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 AlternaScript LLC
2.8.1 Business Overview
2.8.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AlternaScript LLC Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cephalon, Inc.
2.9.1 Business Overview
2.9.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cephalon, Inc. Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ceretropic.
2.10.1 Business Overview
2.10.2 Cognitive and Memory Enhancer Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ceretropic. Cognitive and Memory Enhancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cognitive and Memory Enhancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cognitive and Memory Enhancer Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cognitive and Memory Enhancer Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cognitive and Memory Enhancer Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Cognitive and Memory Enhancer Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cognitive and Memory Enhancer Drugs Market Analysis by Regions
4.1 Global Cognitive and Memory Enhancer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Cognitive and Memory Enhancer Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cognitive and Memory Enhancer Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
4.5 South America Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
5 North America Cognitive and Memory Enhancer Drugs by Countries
5.1 North America Cognitive and Memory Enhancer Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Cognitive and Memory Enhancer Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cognitive and Memory Enhancer Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
6 Europe Cognitive and Memory Enhancer Drugs by Countries
6.1 Europe Cognitive and Memory Enhancer Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Cognitive and Memory Enhancer Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cognitive and Memory Enhancer Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
6.3 UK Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
6.4 France Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cognitive and Memory Enhancer Drugs by Countries
7.1 Asia-Pacific Cognitive and Memory Enhancer Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cognitive and Memory Enhancer Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cognitive and Memory Enhancer Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
7.5 India Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
8 South America Cognitive and Memory Enhancer Drugs by Countries
8.1 South America Cognitive and Memory Enhancer Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Cognitive and Memory Enhancer Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cognitive and Memory Enhancer Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cognitive and Memory Enhancer Drugs by Countries
9.1 Middle East and Africa Cognitive and Memory Enhancer Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cognitive and Memory Enhancer Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Cognitive and Memory Enhancer Drugs Sales and Growth Rate (2013-2018)
10 Global Cognitive and Memory Enhancer Drugs Market Segment by Type
10.1 Global Cognitive and Memory Enhancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cognitive and Memory Enhancer Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Cognitive and Memory Enhancer Drugs Revenue and Market Share by Type (2013-2018)
10.2 Aricept Sales Growth and Price
10.2.1 Global Aricept Sales Growth (2013-2018)
10.2.2 Global Aricept Price (2013-2018)
10.3 Exelon Sales Growth and Price
10.3.1 Global Exelon Sales Growth (2013-2018)
10.3.2 Global Exelon Price (2013-2018)
10.4 Namenda Sales Growth and Price
10.4.1 Global Namenda Sales Growth (2013-2018)
10.4.2 Global Namenda Price (2013-2018)
10.5 Razadyne Sales Growth and Price
10.5.1 Global Razadyne Sales Growth (2013-2018)
10.5.2 Global Razadyne Price (2013-2018)
10.6 Provigil Sales Growth and Price
10.6.1 Global Provigil Sales Growth (2013-2018)
10.6.2 Global Provigil Price (2013-2018)
10.7 Ritalin Sales Growth and Price
10.7.1 Global Ritalin Sales Growth (2013-2018)
10.7.2 Global Ritalin Price (2013-2018)
10.8 Adderall Sales Growth and Price
10.8.1 Global Adderall Sales Growth (2013-2018)
10.8.2 Global Adderall Price (2013-2018)
10.9 Others Sales Growth and Price
10.9.1 Global Others Sales Growth (2013-2018)
10.9.2 Global Others Price (2013-2018)
11 Global Cognitive and Memory Enhancer Drugs Market Segment by Application
11.1 Global Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2013-2018)
11.2 Disease Treatment Sales Growth (2013-2018)
11.3 Academic Performance Sales Growth (2013-2018)
11.4 Athletic Performance Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Cognitive and Memory Enhancer Drugs Market Forecast (2018-2023)
12.1 Global Cognitive and Memory Enhancer Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Cognitive and Memory Enhancer Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Cognitive and Memory Enhancer Drugs Market Forecast (2018-2023)
12.2.2 Europe Cognitive and Memory Enhancer Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Forecast (2018-2023)
12.2.4 South America Cognitive and Memory Enhancer Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cognitive and Memory Enhancer Drugs Market Forecast (2018-2023)
12.3 Cognitive and Memory Enhancer Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Cognitive and Memory Enhancer Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Cognitive and Memory Enhancer Drugs Market Share Forecast by Type (2018-2023)
12.4 Cognitive and Memory Enhancer Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Cognitive and Memory Enhancer Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Cognitive and Memory Enhancer Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cognitive and Memory Enhancer Drugs Picture
Table Product Specifications of Cognitive and Memory Enhancer Drugs
Figure Global Sales Market Share of Cognitive and Mem
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
